Viromed Medical AG (Q11) - Total Assets
Based on the latest financial reports, Viromed Medical AG (Q11) holds total assets worth €339.03 Million EUR (≈ $396.36 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore cash flow to debt ratio of Viromed Medical AG to assess how comfortably operating cash covers total debt obligations.
Viromed Medical AG - Total Assets Trend (2021–2024)
This chart illustrates how Viromed Medical AG's total assets have evolved over time, based on quarterly financial data. See Viromed Medical AG (Q11) shareholders funds for net asset value and shareholders' equity analysis.
Viromed Medical AG - Asset Composition Analysis
Current Asset Composition (December 2024)
Viromed Medical AG's total assets of €339.03 Million consist of 25.7% current assets and 74.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 17.7% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €10.18 Million | 4.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Viromed Medical AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Q11 market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Viromed Medical AG's current assets represent 25.7% of total assets in 2024, a decrease from 64.6% in 2021.
- Cash Position: Cash and equivalents constituted 17.7% of total assets in 2024, down from 63.9% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 4.0% of total assets.
Viromed Medical AG Competitors by Total Assets
Key competitors of Viromed Medical AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gold Fields Ltd ADR
NYSE:GFI
|
USA | $15.23 Billion |
|
AngloGold Ashanti Ltd
JSE:ANG
|
South Africa | ZAC15.77 Billion |
|
Lundin Gold Inc
TO:LUG
|
Canada | CA$1.64 Billion |
|
Alamos Gold Inc
TO:AGI
|
Canada | CA$5.98 Billion |
|
Harmony Gold Mining Company Ltd
BA:HMY
|
Argentina | AR$68.90 Billion |
|
Chifeng Jilong Gold Mining Co Ltd
SHG:600988
|
China | CN¥24.87 Billion |
|
G Mining Ventures Corp.
TO:GMIN
|
Canada | CA$1.95 Billion |
|
Perseus Mining Ltd
TO:PRU
|
Canada | CA$2.72 Billion |
Viromed Medical AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.56 | 0.67 | 0.67 |
| Quick Ratio | 1.27 | 0.58 | 0.58 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €34.32 Million | €-24.98 Million | €-24.98 Million |
Viromed Medical AG - Advanced Valuation Insights
This section examines the relationship between Viromed Medical AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.79 |
| Latest Market Cap to Assets Ratio | 1.76 |
| Asset Growth Rate (YoY) | 138.7% |
| Total Assets | €255.98 Million |
| Market Capitalization | $449.86 Million USD |
Valuation Analysis
Above Book Valuation: The market values Viromed Medical AG's assets above their book value (1.76x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Viromed Medical AG's assets grew by 138.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Viromed Medical AG (2021–2024)
The table below shows the annual total assets of Viromed Medical AG from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €255.98 Million ≈ $299.26 Million |
+138.70% |
| 2023-12-31 | €107.24 Million ≈ $125.37 Million |
+64.74% |
| 2022-12-31 | €65.10 Million ≈ $76.10 Million |
+52.16% |
| 2021-12-31 | €42.78 Million ≈ $50.02 Million |
-- |
About Viromed Medical AG
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.